STRADOS ENDPOINT SUITE
The integrated respiratory endpoint suite for clinical trials — all in one place.
Solutions
Strados Spirometry
Air Next
Cough Monitoring
RESP® Biosensor + Watch
Lung Sound Analysis
RESP® Biosensor
Strados FeNO
NObreath®
eCOA
Patient diaries, questionnaires, and clinical assessments
Our Story
Company background & mission
Intelligence Advantage
How we deliver regulatory-grade evidence
Leadership
Meet the team
News
Press releases & events
Resource Center
Blog, whitepapers & more
Publications
Peer-reviewed research
Research Grant
In-kind support for academic studies
Events & Conferences
Meet us at respiratory conferences
About Strados
The latest press releases, research announcements, and conference presentations from Strados Labs.
The acquisition brings together the gold standard for continuous ambulatory cough monitoring
Read more
The SHORE study, in collaboration with Jefferson Health, will assess the feasibility
The pilot study explores the RESP® Biosensor’s potential to allow for low-effort
Philadelphia, PA, August 25, 2025. Strados Labs, a medical technology company focused
Please join Strados Labs at ATS 2025 for an engaging session on
Strados Labs looks forward to participating in the American Thoracic Society (ATS)
The new program provides eligible research studies with in-kind support for the
The study will evaluate continuous lung sound monitoring for the early detection
Strados Labs, a medical technology company, is excited to announce a new
August 6, 2024 — Minneapolis, MN — Delve Health, a leader in
Strados Labs, a digital health company focused on improving the lives of
Strados Labs is excited to announce its participation in a groundbreaking project
Strados Labs returned to the Respiratory Innovation Summit (RIS), taking place at
We are thrilled to announce that through our various partnerships with life
Strados Labs’ RESP™ Biosensor is currently being used in a clinical trial
PHILADELPHIA, PA – August 31, 2023 – Strados Labs is thrilled to announce its
Clario has partnered with Strados Labs to offer its customers the RESP™
Nick Delmonico, Cofounder and CEO of Strados Labs presented live at ATA
PENSACOLA, FLORIDA, UNITED STATES, February 2, 2023 — Strados Labs announced today that
Starting in early 2023 the biopharmaceutical company will use the Strados RESP™
Recognized in the Wearable Category for the first-of-its-kind smart sensor platform for
Philadelphia, PA May 3, 2022 — Strados Labs, a medical technology company harnessing the power
Funding will help Strados advance the power of its smart sensors to
Funding to fuel next key milestones as company continues to target asthma, COPD
Strados Labs harnesses the power of smart sensors and machine learning to aid in
CE Mark expands the company’s reach to support customers on a global
Philadelphia, PA December 22, 2020 — Strados Labs, a health technology developer of
Small Business Innovation Research Program Provides Seed Funding for R&D Philadelphia, PA,
As hospitals and ICUs begin to fill following the coronavirus outbreak, this
Houston, TX and Philadelphia, PA, August 22, 2019 – An innovative program at
Philadelphia, PA, February 12, 2019 — Strados Labs, creator of the world’s first
Tell us about your program and we'll help you design the right respiratory endpoint strategy.
